Stock listing
NASDAQ:CRBP Corbus Pharmaceuticals Holdings, Inc. Stock
Home listing (NASDAQ) of Corbus Pharmaceuticals Holdings, Inc.
Follow Corbus Pharmaceuticals Holdings, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:CRBP
$4.22 USD 0.00 (0.0%)
Close on Oct 30, 2026
- Day range
- $3.95 – $4.31 USDOct 30, 2026
- Volume
- 2.32M sharesOct 30, 2026
- Market cap
- $81.62M USDAt the close on Oct 30, 2026 · price × 19.34M shares outstanding
- 52-week range
- $3.87 – $12.88 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $6.66M USDMedian day 712,413 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CRBP · Home | $4.22 USD | 0.00 (0.0%) | 2,317,176 | $4.20 | $4.31 | $3.95 | $4.22 | Close on Oct 30, 2026 |
| LSE:0SZI | $4.06 USD | +0.05 (+1.2%) | 15,228 | $3.981 | $4.22 | $3.98 | $4.01 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:CRBP · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $4.22 | 0.00 | 0.0% | $4.20 | $4.31 | $3.95 | 2,317,176 | |
| $4.22 | -0.03 | -0.7% | $4.25 | $4.34 | $4.10 | 1,482,194 | |
| $4.25 | +0.10 | +2.4% | $4.13 | $4.27 | $4.085 | 750,810 | |
| $4.15 | +0.16 | +4.0% | $4.00 | $4.205 | $3.98 | 716,626 | |
| $3.99 | -0.06 | -1.5% | $4.05 | $4.076 | $3.87 | 847,346 | |
| $4.05 | -0.08 | -1.9% | $4.08 | $4.08 | $3.93 | 372,430 | |
| $4.13 | -0.155 | -3.6% | $4.37 | $4.52 | $4.032 | 983,758 | |
| $4.285 | -0.135 | -3.1% | $4.45 | $4.565 | $4.28 | 625,935 | |
| $4.42 | -0.04 | -0.9% | $4.48 | $4.68 | $4.405 | 477,643 | |
| $4.46 | -0.06 | -1.3% | $4.54 | $4.67 | $4.38 | 735,788 | |
| $4.52 | +0.19 | +4.4% | $4.35 | $4.72 | $4.22 | 1,065,300 | |
| $4.33 | -0.08 | -1.8% | $4.40 | $4.62 | $4.23 | 1,089,700 | |
| $4.41 | -0.37 | -7.7% | $4.72 | $4.82 | $4.37 | 1,340,000 | |
| $4.78 | -0.49 | -9.3% | $5.24 | $5.26 | $4.76 | 648,300 | |
| $5.27 | -0.11 | -2.0% | $5.35 | $5.403 | $5.11 | 1,010,700 | |
| $5.38 | +0.11 | +2.1% | $5.25 | $5.61 | $5.171 | 867,900 | |
| $5.27 | -0.22 | -4.0% | $5.80 | $5.80 | $5.13 | 1,346,000 | |
| $5.49 | -0.29 | -5.0% | $5.72 | $5.795 | $5.47 | 1,241,900 | |
| $5.78 | -0.07 | -1.2% | $5.87 | $5.995 | $5.65 | 707,400 | |
| $5.85 | -0.28 | -4.6% | $6.17 | $6.17 | $5.83 | 793,000 | |
| $6.13 | -0.21 | -3.3% | $6.59 | $6.68 | $6.06 | 834,800 | |
| $6.34 | -0.48 | -7.0% | $6.80 | $6.82 | $6.25 | 802,600 | |
| $6.82 | +0.19 | +2.9% | $6.75 | $6.88 | $6.57 | 507,000 | |
| $6.63 | -0.29 | -4.2% | $6.93 | $7.05 | $6.59 | 785,800 | |
| $6.92 | -0.22 | -3.1% | $7.12 | $7.18 | $6.88 | 932,000 | |
| $7.14 | -0.31 | -4.2% | $7.50 | $7.59 | $6.97 | 708,200 | |
| $7.45 | -0.29 | -3.7% | $7.69 | $7.76 | $7.125 | 757,800 | |
| $7.74 | -0.135 | -1.7% | $7.83 | $7.98 | $7.66 | 787,300 | |
| $7.875 | +0.225 | +2.9% | $7.73 | $7.95 | $7.61 | 452,800 | |
| $7.65 | +0.17 | +2.3% | $7.51 | $7.79 | $7.42 | 499,700 | |
| $7.48 | +0.22 | +3.0% | $7.22 | $7.67 | $7.154 | 1,155,000 | |
| $7.26 | 0.00 | 0.0% | $7.26 | $7.38 | $7.03 | 992,600 | |
| $7.26 | +0.34 | +4.9% | $6.86 | $7.50 | $6.82 | 1,226,500 | |
| $6.92 | -1.16 | -14.4% | $8.08 | $8.08 | $6.325 | 3,749,600 | |
| $8.08 | -0.04 | -0.5% | $7.93 | $8.70 | $7.66 | 8,396,500 | |
| $8.12 | -0.12 | -1.5% | $8.38 | $8.495 | $7.95 | 2,347,300 | |
| $8.24 | -0.62 | -7.0% | $8.75 | $8.79 | $8.21 | 646,700 | |
| $8.86 | -1.735 | -16.4% | $10.60 | $10.72 | $8.845 | 1,003,800 | |
| $10.60 | -0.485 | -4.4% | $11.07 | $11.07 | $10.31 | 915,400 | |
| $11.08 | -0.38 | -3.3% | $11.37 | $11.45 | $11.06 | 222,500 | |
| $11.46 | -0.02 | -0.2% | $11.52 | $11.60 | $11.22 | 475,300 | |
| $11.48 | +0.20 | +1.8% | $11.27 | $11.56 | $10.60 | 664,400 | |
| $11.28 | +0.37 | +3.4% | $10.81 | $11.37 | $10.58 | 901,300 | |
| $10.91 | 0.00 | 0.0% | $10.86 | $11.00 | $10.39 | 473,600 | |
| $10.91 | -0.22 | -2.0% | $11.13 | $11.29 | $10.75 | 584,300 | |
| $11.13 | -0.17 | -1.5% | $11.28 | $11.45 | $11.11 | 325,900 | |
| $11.30 | -0.01 | -0.1% | $11.36 | $11.55 | $10.96 | 391,800 | |
| $11.31 | +0.62 | +5.8% | $10.90 | $11.35 | $10.79 | 1,281,867 | |
| $10.69 | +0.31 | +3.0% | $10.20 | $10.88 | $9.68 | 1,313,673 | |
| $10.38 | +0.54 | +5.5% | $9.97 | $10.42 | $9.895 | 604,000 | |
| $9.84 | -0.15 | -1.5% | $10.00 | $10.05 | $9.73 | 300,400 | |
| $9.99 | -0.09 | -0.9% | $10.20 | $10.42 | $9.86 | 345,700 | |
| $10.08 | -0.41 | -3.9% | $10.49 | $10.75 | $9.95 | 329,100 | |
| $10.49 | +0.40 | +4.0% | $10.06 | $10.58 | $10.05 | 869,300 | |
| $10.09 | +0.01 | +0.1% | $10.04 | $10.29 | $9.88 | 425,800 | |
| $10.08 | +0.32 | +3.3% | $10.05 | $10.39 | $9.68 | 695,900 | |
| $9.76 | +0.25 | +2.6% | $9.51 | $9.91 | $9.40 | 551,800 | |
| $9.51 | +0.05 | +0.5% | $9.54 | $9.71 | $9.42 | 423,600 | |
| $9.46 | -0.71 | -7.0% | $10.09 | $10.25 | $9.365 | 339,800 | |
| $10.17 | +0.43 | +4.4% | $9.74 | $10.23 | $9.74 | 357,100 | |
| $9.74 | +0.17 | +1.8% | $9.24 | $9.84 | $9.18 | 158,000 | |
| $9.57 | +0.17 | +1.8% | $9.49 | $9.82 | $9.38 | 236,000 | |
| $9.40 | +0.48 | +5.4% | $9.04 | $9.45 | $8.985 | 265,000 | |
| $8.92 | -0.05 | -0.6% | $9.01 | $9.16 | $8.71 | 132,000 | |
| $8.97 | -0.08 | -0.9% | $9.06 | $9.16 | $8.615 | 351,700 | |
| $9.05 | +0.13 | +1.5% | $8.90 | $9.36 | $8.79 | 138,800 |
- Ticker
- NASDAQ:CRBP
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 22, 2026
Corbus Pharmaceuticals to Present Late Breaking CRB-913 Data from Canyon-1 Study at Obesity Week® 2026
Latest deck · Oct 15, 2026
Investor Presentation (October 2026)
Investor deck · 62 slides
Calls
Replays
Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) Q3 2020 Earnings Call
Tue, Nov 10, 2020 · 8:30 AM ET
Watch TranscriptCorbus Pharmaceuticals Holdings (NASDAQ:CRBP) Q2 2020 Earnings Call
Thu, Aug 06, 2020 · 8:30 AM ET
Watch TranscriptCorbus Pharmaceuticals Holdings (NASDAQ:CRBP) Q1 2020 Earnings Call
Mon, May 11, 2020 · 8:30 AM ET
Watch Transcript
Latest news
Corbus Pharmaceuticals to Present Late Breaking CRB-913 Data from Canyon-1 Study at Obesity Week® 2026
Oct 22, 2026
Closed $4.13 (-3.6%) on Oct 22, 2026
Corbus Pharmaceuticals Announces First Patient Dosed in TEMPO-1 Registrational Study of CRB-701 in Patients with 2L+ Oropharyngeal Cancer
Sep 29, 2026
Closed $6.63 (-4.2%) on Sep 29, 2026
Corbus Pharmaceuticals Announces Positive Topline Data from CANYON-1 Study of Daily Oral CRB-913 for the Treatment of Obesity
Sep 14, 2026
Closed $8.08 (-0.5%) on Sep 14, 2026
Corbus Pharmaceuticals to Host Conference Call to Discuss Topline Data from CANYON-1 Clinical Trial and the Potential of CRB-913 In Obesity
Sep 11, 2026
Closed $8.08 (-0.5%) on Sep 14, 2026
Corbus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 17, 2026
Closed $10.49 (+4.0%) on Aug 17, 2026
Corbus Pharmaceuticals Reports Q2 2026 Financial Results and Provides a Corporate Update
Aug 6, 2026
Closed $9.74 (+1.8%) on Aug 6, 2026
Corbus Pharmaceuticals Announces Last Patient Last Visit in CANYON-1 Study of CRB-913 for the Treatment of Obesity
Aug 4, 2026
Closed $9.40 (+5.4%) on Aug 4, 2026
Corbus Pharmaceuticals Appoints Leonardo Viana Nicacio, M.D. as Chief Medical Officer
Jul 6, 2026
Closed $9.00 (-2.7%) on Jul 6, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 62 slides · Oct 15, 2026
Investor Presentation (September 2026)
Investor deck · 58 slides · Sep 14, 2026
Investor Presentation (May 2026)
Investor deck · 58 slides · May 26, 2026
Investor Presentation (March 2026)
Investor deck · 63 slides · Mar 9, 2026
Corbus Pharmaceuticals Holdings, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 25 in the last 12 months · 116 in all · newest Oct 22, 2026 · oldest 2019
- Calls
- 3 calls with a replay · 3 with a transcript · latest Nov 10, 2020
- Decks
- 45 decks · latest Oct 15, 2026
Where Corbus Pharmaceuticals Holdings, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CRBP · Home listing · This page | NASDAQ | United States | USD |
| Lang & Schwarz:A3D54P | Lang & Schwarz | Germany | EUR |
| gettex:3371 | gettex | Germany | EUR |
| LS Exchange:A3D54P | LS Exchange | Germany | EUR |
| BOATS:CRBP | BOATS | United States | USD |
| LSE:0SZI | LSE | United Kingdom | USD |
| Tradegate:3371 | Tradegate | Germany | EUR |
| Dusseldorf:3371 | Dusseldorf | Germany | EUR |
| Frankfurt:3371 | Frankfurt | Germany | EUR |
| Hamburg:3371 | Hamburg | Germany | EUR |
| Munich:3371 | Munich | Germany | EUR |
| Stuttgart:3371 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Corbus Pharmaceuticals Holdings, Inc.